Novavax's updated protein-based Covid-19 vaccine approved by U.S. FDA
Submitted by mike kraft on
This vaccine is effective against EG.5, the currently dominant coronavirus strain in the United States, and like Pfizer and Moderna’s mRNA vaccines, it has been updated to target the XBB Omicron subvariant.